Skip to main content Skip to main navigation menu Skip to site footer

Lung damage reduction due to reperfusion injury of acute lower limb ischemia with and without pentoxifylline and vitamin c combination therapy: histopathological evaluation

  • Maikel Triyudi Tappang ,
  • Yan Efrata Sembiring ,
  • Willy Sandhika ,


Abstract

Several studies report an incidence of acute limb ischemia of approximately 1.5 cases per 10,000 persons per year. The mortality rate from acute limb ischemia ranges from 15-to 20% and the morbidity rate from 25% by amputation and 5-to 25% to fasciotomy. Revascularization is the main goal in the management of acute limb ischemia. Reperfusion of ischemic limbs can save limbs from amputation, but Ischemia-reperfusion injury can also cause systemic damage in the form of damage to body organs (lung, liver, kidney, heart, and brain tissue) which increases morbidity and mortality rates. Lung tissue is an easily affected target organ, and damage from Ischemia-reperfusion injury can cause acute lung injury and acute respiratory distress syndrome. These conditions damage the endothelium and epithelium of the lung parenchyma resulting in edema and impaired gas diffusion with a very high mortality rate of around 25-40%. The combination therapy of Pentoxifylline and Vitamin C in reducing the effect of Ischemia-reperfusion injury on lung tissues and have shown a protective effect of lung tissue damage due to ischemia-reperfusion injury in lower limbs.

Keywords: Acute limb Ischemia reperfusion injury lung vitamin C pentoxifylline

References

  1. Zemaitis MR, Boll JM, Dreyer MA. Peripheral Arterial Disease. 2022 Jul 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 28613496.
  2. Editorial A. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Russ J Cardiol [Internet]. 2018;(8):164–221. Available from: http://dx.doi.org/10.15829/1560-4071-2018-8-164-221
  3. Editorial. Correction to: 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation [Internet]. 2017;135(12). Available from: http://dx.doi.org/10.1161/cir.0000000000000501
  4. Wu MY, Yiang GT, Liao WT, Tsai APY, Cheng YL, Cheng PW, et al. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem [Internet]. 2018;46(4):1650–67. Available from: http://dx.doi.org/10.1159/000489241
  5. Santos CHM dos, Aydos RD, Nogueira Neto E, Miiji LNO, Cassino PC, Alves II, et al. Evaluation of Pulmonary Reperfusion Injury in Rats Undergoing Mesenteric Ischemia and Reperfusion and Protective Effect of Postconditioning on this Process. Brazilian J Cardiovasc Surg [Internet]. 2015;30(5):533–7. Available from: https://pubmed.ncbi.nlm.nih.gov/26735599
  6. Kearns SR, Kelly CJ, Barry M, Abdih H, Condron C, Leahy A, et al. Vitamin C Reduces Ischaemia-reperfusion-induced Acute Lung Injury. Eur J Vasc Endovasc Surg [Internet]. 1999;17(6):533–6. Available from: http://dx.doi.org/10.1053/ejvs.1999.0833
  7. Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol [Internet]. 2015/10/08. 2015 Dec;6:524–51. Available from: https://pubmed.ncbi.nlm.nih.gov/26484802
  8. Leurcharusmee P, Sawaddiruk P, Punjasawadwong Y, Chattipakorn N, Chattipakorn SC. The Possible Pathophysiological Outcomes and Mechanisms of Tourniquet-Induced Ischemia-Reperfusion Injury during Total Knee Arthroplasty. Oxid Med Cell Longev [Internet]. 2018 Nov 5;2018:8087598. Available from: https://pubmed.ncbi.nlm.nih.gov/30524661
  9. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral Artery Disease: Past, Present, and Future. Am J Med. 2019;132(10):1133-1141. Available from doi: 10.1016/j.amjmed.2019.04.043.
  10. Paradis S, Charles AL, Meyer A, Lejay A, Scholey JW, Chakfé N, et al. Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion. Am J Physiol Cell Physiol [Internet]. 2016/04/13. 2016 Jun 1;310(11):C968–82. Available from: https://pubmed.ncbi.nlm.nih.gov/27076618
  11. Wang L, Chen F, Pan Y, Lin L, Xiong X. Effects of FTY720 on Lung Injury Induced by Hindlimb Ischemia Reperfusion in Rats. Mediators Inflamm [Internet]. 2017/11/09. 2017;2017:5301312. Available from: https://pubmed.ncbi.nlm.nih.gov/29249870
  12. Stone ML, Sharma AK, Zhao Y, Charles EJ, Huerter ME, Johnston WF, et al. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol [Internet]. 2015/04/24. 2015 Jun 15;308(12):L1245–52. Available from: https://pubmed.ncbi.nlm.nih.gov/25910934
  13. Kay RH. Cardiovascular Therapeutics, A Companion to Braunwald’s Heart Disease, 2nd ed. Hear Dis [Internet]. 2002;4(4):272. Available from: http://dx.doi.org/10.1097/00132580-200207000-00010
  14. Akahane HGK, Gomes RZ, Paludo KS, Linhares F, Lopes L. The influence of allopurinol and post-conditioning on lung injuries induced by lower-limb ischemia and reperfusion in Wistar rats. Acta Cir Bras [Internet]. 2017;32(9):746–54. Available from: http://dx.doi.org/10.1590/s0102-865020170090000007
  15. Romano M, Cianci E, Simiele F, Recchiuti A. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. Eur J Pharmacol [Internet]. 2015;760:49–63. Available from: http://dx.doi.org/10.1016/j.ejphar.2015.03.083
  16. Erkut B, özyazicioğlu A, Karapolat BS, Koçoğullari CU, Keles S, Ateç A, et al. Effects of Ascorbic Acid, Alpha-Tocopherol and Allopurinol on Ischemia-Reperfusion Injury in Rabbit Skeletal Muscle: An Experimental Study. Drug Target Insights [Internet]. 2007;2:DTI.S303. Available from: http://dx.doi.org/10.4137/dti.s303
  17. Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 2015 Dec;6:524-551. doi: 10.1016/j.redox.2015.08.020. Epub 2015 Oct 8. PMID: 26484802; PMCID: PMC4625011.
  18. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med [Internet]. 2018;54(4):287–93. Available from: http://dx.doi.org/10.1016/j.ajme.2017.09.001
  19. Takhtfooladi HA, Hesaraki S, Razmara F, Takhtfooladi MA, Hajizadeh H. Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury. J Bras Pneumol [Internet]. 2016;42(1):9–14. Available from: https://pubmed.ncbi.nlm.nih.gov/26982035
  20. Effects of Sulforaphane in brain ischemic reperfusion injury in rats. Int J Pharm Res [Internet]. 2020;12(04). Available from: http://dx.doi.org/10.31838/ijpr/2020.12.04.505
  21. Ascorbic Acid (Vitamin C) and Iloprost Attenuate the Lung Injury Caused by Ischemia/Reperfusion of the Lower Extremities of Rats (Ann Vase Surg 2006;20:49-55). Ann Vasc Surg [Internet]. 2006;20(6):849. Available from: http://dx.doi.org/10.1007/s10016-006-9082-3

How to Cite

Tappang, M. T., Sembiring, Y. E. ., & Sandhika, W. . (2022). Lung damage reduction due to reperfusion injury of acute lower limb ischemia with and without pentoxifylline and vitamin c combination therapy: histopathological evaluation. Bali Medical Journal, 11(3), 1080–1084. https://doi.org/10.15562/bmj.v11i3.3684
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
0

Total
0

Share

Search Panel

Maikel Triyudi Tappang
Google Scholar
Pubmed
BMJ Journal

Yan Efrata Sembiring
Google Scholar
Pubmed
BMJ Journal

Willy Sandhika
Google Scholar
Pubmed
BMJ Journal